PHARMACY

Cynthia Schwalm, who has held positions at Ipsen, Eisai, Amgen and J&J, is joining Hikma's board June 1.

Adderall, including generic versions, had a market value of about $361 million for the 12 months ended January 2019, Lannett said.

Members of Co-op Power, the group purchasing organization of Garden State Pharmacy Owners, will have access to Pharma Logistics' onsite and box and ship services.

Pfizer's Trazimera provides treatment for HER2 breast and gastric cancers.

The rivastigmine transdermal system had a market value of approximately $214 million for the 12 months ended January 2019.

The Association for Accessible Medicines criticized the Administration's proposal to amend the 180-day period of exclusivity for first generics.

NACDS president and CEO Steve Anderson emphasized DIR fee reform’s role in lowering patients’ out of pocket costs and reducing overall healthcare costs in a Morning Consult op-ed.

PDL BioPharma is introducing an authorized generic of Tekturna for hypertension.